Lisinopril vs Sars-Cov-2 Virus Spike Protein

## Lisinopril vs Sars-Cov-2 Virus Spike Protein: Overview

This comparison examines the pharmacological differences between **Lisinopril** and **Sars-Cov-2 Virus Spike Protein**.

## Mechanism of Action

**Lisinopril**: ACE inhibitor preventing conversion of angiotensin I to angiotensin II.

## Pharmacokinetics

**Half-life**: Lisinopril — 12 hours; Sars-Cov-2 Virus Spike Protein — N/A.

## Chemical Properties

**Molecular Formula**: Lisinopril — C21H31N3O5; Sars-Cov-2 Virus Spike Protein — N/A.

**Molecular Weight**: Lisinopril — 405.4900 g/mol; Sars-Cov-2 Virus Spike Protein — N/A.

**Type**: Lisinopril — Small molecule; Sars-Cov-2 Virus Spike Protein — Vaccine component.